Polysaccharides from Tetrastigma Hemsleyanum Diels et Gilg ameliorated inflammatory bowel disease by rebuilding the intestinal mucosal barrier and inhibiting inflammation through the SCFA-GPR41/43 signaling pathway

Yue Lin,Yishan Lv,Zian Mao,Xingcan Chen,Yuchi Chen,Bingqi Zhu,Ying Yu,Zhishan Ding,Fangmei Zhou
DOI: https://doi.org/10.1016/j.ijbiomac.2023.126167
IF: 8.2
2023-08-12
International Journal of Biological Macromolecules
Abstract:In this study, the therapeutic effects of Tetrastigma hemsleyanum polysaccharide (THP) on inflammatory bowel disease (IBD) and its possible mechanisms were investigated based on the IBD mouse model induced by dextran sodium sulfate (DSS) and the lipopolysaccharide (LPS)-stimulated Caco-2 cell model. THP significantly alleviated the signs and symptoms of DSS-induced IBD mice, including the reduced weight, shortened colonic length, and increased colitis disease activity index. In vivo , THP significantly reduced inflammatory cell infiltration and oxidative damage, promoted intestinal mucus secretion, and restored the integrity of the intestinal epithelial barrier and mucus barrier. Furthermore, THP reversed the changes in the intestinal flora of colonized mice and restored the levels of short-chain fatty acids (SCFAs) by increasing the abundance of potentially beneficial bacteria and increasing the abundance of butyrate-producing bacteria. In addition, THP upregulated the expression of G-protein-coupled receptors (GPR41 and GPR43) both in vivo and in vitro . In summary, the current investigation showed that THP effectively protected against intestinal inflammation and impairment in the intestinal barrier in the setting of DSS-induced IBD, possibly by regulating gut microbiota structure and corresponding SCFA metabolites, and the pathway of SCFAs action may be related to SCFA-GPR41/43 signaling pathway.
polymer science,biochemistry & molecular biology,chemistry, applied
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the effective treatment of Inflammatory Bowel Disease (IBD). Specifically, the research aims to explore the therapeutic effect of polysaccharide (THP) from *Tetrastigma hemsleyanum Diels et Gilg* on IBD and its possible mechanism of action. By using the DSS - induced mouse IBD model and the LPS - stimulated Caco - 2 cell model, the study found that THP can significantly improve the symptoms of DSS - induced IBD mice, including reducing weight loss, shortening colon length and increasing the colitis disease activity index. In addition, THP can also reduce inflammatory cell infiltration and oxidative damage, promote intestinal mucus secretion, and restore the integrity of the intestinal epithelial barrier and mucus barrier. Further research shows that THP can play its anti - inflammatory role and protect the intestinal barrier function by regulating the structure of the gut microbiota and the corresponding short - chain fatty acids (SCFAs) metabolites, as well as through the SCFA - GPR41/43 signaling pathway. Therefore, this study provides a theoretical basis for the development and application of *Tetrastigma hemsleyanum Diels et Gilg* resources and a scientific basis for the treatment and management of IBD.